ストックスクリーナーアプリを入手
1.56
2.69%
0.03
前日終値:
$1.53
開ける：
$1.53
24時間の取引高:
135.98K
Relative Volume:
0.71
時価総額：
$82.28M
収益：
-
当期純損益:
$-51.47M
株価収益率:
-1.56
EPS:
-1
ネットキャッシュフロー:
$-47.50M
1週間 パフォーマンス:
+4.75%
1か月 パフォーマンス:
-2.41%
6か月 パフォーマンス:
+0.72%
1年 パフォーマンス:
-46.92%
1日の値動き範囲:
$1.53
$1.6206
1週間の範囲:
$1.46
$1.6206
52週間の値動き範囲:
$1.40
$2.98
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
PMVP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.555 | 82.28M | 0 | -51.47M | -47.50M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.21 | 105.50B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
721.11 | 78.93B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
626.54 | 37.63B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.76 | 30.08B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
116.49 | 27.58B | 3.30B | -501.07M | 1.03B | -2.1146 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-08 | アップグレード | Oppenheimer | Perform → Outperform |
| 2024-05-13 | 開始されました | Craig Hallum | Buy |
| 2024-04-12 | 開始されました | Jefferies | Buy |
| 2023-12-27 | 開始されました | Ladenburg Thalmann | Buy |
| 2022-03-02 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-09-22 | アップグレード | Goldman | Neutral → Buy |
| 2021-08-19 | 開始されました | Oppenheimer | Perform |
| 2021-08-02 | 開始されました | Guggenheim | Buy |
| 2021-07-29 | 開始されました | H.C. Wainwright | Buy |
| 2020-10-20 | 開始されました | BofA Securities | Buy |
| 2020-10-20 | 開始されました | Cowen | Outperform |
| 2020-10-20 | 開始されました | Evercore ISI | Outperform |
| 2020-10-20 | 開始されました | Goldman | Neutral |
すべてを表示
Pmv Pharmaceuticals Inc (PMVP) 最新ニュース
Layoff Tracker: Stubborn Layoff Trend Continues Across Biopharma in 2024 - BioSpace
When Should You Buy Premier Investments Limited (ASX:PMV)? - Yahoo Finance
Discover 3 US Penny Stocks With Market Caps Over $40M - Simply Wall St
ArrowMark Colorado Holdings LLC Purchases 842,509 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - MarketBeat
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Given Average Rating of "Buy" by Brokerages - MarketBeat
Sio Capital Management LLC Boosts Stock Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - MarketBeat
PMVP (PMV Pharmaceuticals) 6-Month Price Index : 0.78 (As of Nov. 28, 2024) - GuruFocus.com
PMV Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer - MSN
Sionna Therapeutics Appoints Laurie Stelzer to its Board of Directors - citybiz
ArrowMark Colorado Holdings LLC Expands Stake in PMV Pharmaceuti - GuruFocus.com
BML Capital Management LLC Grows Stock Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - MarketBeat
Icahn Enterprises Releases Third Quarter 2024 Financial Results - Defense World
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Receives $5.80 Average Target Price from Brokerages - MarketBeat
PMV Pharmaceuticals (NASDAQ:PMVP) Upgraded at Oppenheimer - MarketBeat
Oppenheimer raises PMVP rating to Outperform, sets stock target on Q3 results - Investing.com UK
PMV Pharmaceuticals Inc (PMVP) Quarterly 10-Q Report - Quartz
PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results - The Manila Times
Karyopharm stock gains as late-stage trial changes (KPTI:NASDAQ) - Seeking Alpha
Rezatapopt Monotherapy Remains Under Study Following Discontinuation of Combination Cohort in TP53+ Solid Tumors - OncLive
Dr Cristofanilli on Applications for Liquid Biopsy–Based MRD Testing in Breast Cancer - OncLive
CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines - Yahoo Finance
US Penny Stocks To Consider In October 2024 - Simply Wall St
PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial - GlobeNewswire
New Global Hematology Journal Strives to Feature Innovative and Adaptable Research - OncLive
Biodexa Pharmaceuticals (NASDAQ:BDRX) Stock Quotes, Forecast and News Summary - Benzinga
SG Americas Securities LLC Invests $554,000 in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Defense World
Menin Inhibitors for AML: A Roundtable on the Latest Advances - OncLive
SG Americas Securities LLC Grows Stake in Stellantis (NYSE:STLA) - Defense World
ELVN-001 Appears Safe and Effective in Relapsed/Refractory CML - OncLive
Envestnet Asset Management Inc. Sells 2,501 Shares of Juniper Networks, Inc. (NYSE:JNPR) - Defense World
Point72 Asia Singapore Pte. Ltd. Takes $101,000 Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
PMV Pharmaceuticals (NASDAQ:PMVP) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
PRISM MarketView Features Q&A with Dr. Michael Chancellor: - GlobeNewswire
Pawan Singh sharing his grief with Mata Rani, asking questions from his mind, Pawan Singh sharing his grief with Mata Rani, asking questions from his mind - AnyTV News
Small Cap Stocks: Plexus, Parkmead, Proton Motor - The Armchair Trader
Stock market news: PC Jeweller shares hit 5% upper circuit- Check Details - MSN
Vanguard Personalized Indexing Management LLC Increases Position in PDD Holdings Inc. (NASDAQ:PDD) - Defense World
2 ASX shares I can’t ignore: PME and SOL - Rask Media
40% women with PCOD may get diabetes: Experts - The Times of India
Parvin Dabas, Pro Panja League Co-Founder, In ICU After Road Accident - Pratidin Time
Agency News | ⚡Pro Panja League Co-Founder and Actor Parvin Dabas Admitted to ICU Following Car Accident - LatestLY
Should PME shares be on your watchlist? - Rask Media
Power Mech Shares Gain on Securing Orders Worth Rs 865 Crore - EquityPandit
Power Mech rises on Rs 865-cr order win from Vedanta's subsidiary - Business Standard
Bowers & Wilkins Launches Px7 S2e “Ruby Red” and Px8 “Dark Forest” - HYPEBEAST
Bowers & Wilkins adds two new colors to PX7 S2e & PX8 headphones - Gstyle magazine
PMV Pharmaceuticals executive sells over $10k in company stock By Investing.com - Investing.com Canada
PMV Pharmaceuticals CFO sells over $4,300 in company stock By Investing.com - Investing.com Canada
PMV Pharmaceuticals executive sells over $10k in company stock - Investing.com India
Insider Selling: PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Insider Sells 7,218 Shares of Stock - MarketBeat
PMV Pharmaceuticals CFO sells over $4,300 in company stock - Investing.com India
Pmv Pharmaceuticals Inc (PMVP) 財務データ
収益
当期純利益
現金流量
EPS
Pmv Pharmaceuticals Inc (PMVP) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Carulli Michael | Chief Financial Officer |
Sep 11 '24 |
Sale |
1.50 |
2,891 |
4,347 |
88,395 |
0.54%
0.66%
大文字化:
|
ボリューム (24 時間):